jama naion semaglutide short for “nonarteritic anterior ischemic optic neuropathy” is a cause of sudden painless permanent blindness. The incidence is 2-10 people per 100 000. NAION is thought to be caused by reduced Adults prescribed semaglutide may have

"The risk of developing these severe side effects is very small, but it is important that patients and healthcare professionals are aware and alert to the associated symptoms." In the UK, the most commonly used GLP-1 therapies are Novo Nordisk's semaglutide-based Ozempic for diabetes and Wegovy for obesity, as well as Eli Lilly's Mounjaro (tirzepatide), which are all given as weekly injections

Jensterle, Mojca, et al

Most studies show noticeable effects after 8 to 12 weeks of daily use combined with strength training

And beyond all of that you've packed for the actual trip

Treatment decisions are made during an individual medical evaluation with a licensed provider